These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31536987)

  • 1. Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas.
    Demirdas S; Hense J; Dührsen U; Hüttmann A
    Oncol Res Treat; 2019; 42(11):580-588. PubMed ID: 31536987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
    Papaxoinis G; Fountzilas G; Rontogianni D; Dimopoulos MA; Pavlidis N; Tsatalas C; Pectasides D; Xiros N; Economopoulos T
    Ann Oncol; 2008 Apr; 19(4):780-6. PubMed ID: 18156143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic transformation in marginal zone lymphomas†.
    Conconi A; Franceschetti S; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Stathis A; Moccia AA; Bertoni F; Ramponi A; Mazzucchelli L; Cavalli F; Gaidano G; Zucca E
    Ann Oncol; 2015 Nov; 26(11):2329-35. PubMed ID: 26400898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma.
    Wang L; Ye G; Liu Z; Shi L; Zhan C; Gu J; Luo R; Lin Z; Ge D; Wang Q
    Cancer Med; 2019 Dec; 8(18):7660-7668. PubMed ID: 31691549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
    Martinelli G; Ryan G; Seymour JF; Nassi L; Steffanoni S; Alietti A; Calabrese L; Pruneri G; Santoro L; Kuper-Hommel M; Tsang R; Zinzani PL; Taghian A; Zucca E; Cavalli F
    Ann Oncol; 2009 Dec; 20(12):1993-9. PubMed ID: 19570964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Zucca E; Conconi A; Pedrinis E; Cortelazzo S; Motta T; Gospodarowicz MK; Patterson BJ; Ferreri AJ; Ponzoni M; Devizzi L; Giardini R; Pinotti G; Capella C; Zinzani PL; Pileri S; López-Guillermo A; Campo E; Ambrosetti A; Baldini L; Cavalli F;
    Blood; 2003 Apr; 101(7):2489-95. PubMed ID: 12456507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital lymphoma: diagnostic approach and treatment outcome.
    Eckardt AM; Lemound J; Rana M; Gellrich NC
    World J Surg Oncol; 2013 Mar; 11():73. PubMed ID: 23506357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
    White WL; Ferry JA; Harris NL; Grove AS
    Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study).
    Govi S; Christie D; Mappa S; Marturano E; Bruno-Ventre M; Messina C; Medina EA; Porter D; Radford J; Heo DS; Park Y; Pro B; Jayamohan J; Pavlakis N; Zucca E; Gospodarowicz M; Ferreri AJ;
    Leuk Lymphoma; 2014 Aug; 55(8):1796-9. PubMed ID: 24295130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases.
    Oh SY; Ryoo BY; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Kim HJ; Kwon HC; Bang SM; Kim JH; Park J; Lee SS; Kim HY; Park K
    Am J Hematol; 2007 Jun; 82(6):446-52. PubMed ID: 17266060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.
    Tracy SI; Larson MC; Feldman AL; Maurer MJ; Novak AJ; Slager SL; Villasboas JC; Allmer C; Habermann TM; Farooq U; Syrbu S; Cerhan JR; Link BK
    Am J Hematol; 2019 Jun; 94(6):658-666. PubMed ID: 30916801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.